Navigation Links
Obesity Hormone -' Leptin' may treat Metabolic Disorder

According to new findings, Leptin- the so-called obesity hormone may help patients in treating a rare disorder marked by a loss of fat tissue and other metabolic abnormalities.The study's author found that the results of this study lays the foundation for research into the role of leptin in common metabolic conditions such as type 2 diabetes. //

Dr. Elif Oral and her colleagues found that a lab-engineered version of leptin, which is usually produced by fat cells, improved several metabolic problems in nine women with lipodystrophy. These patients had little or no fat tissue due to either a genetic defect or an abnormal immune system attack on the body's own tissue.

Along with low blood levels of leptin, the condition is typically marked by high levels of blood fats called triglycerides, resistance to the blood-sugar-regulating hormone insulin, and diabetes. Diabetes occurs when the body loses sensitivity to insulin and blood sugar levels rise out of control. Typically, this rare form of lipodystrophy is treated with a combination of insulin and other diabetes drugs, as well as cholesterol-lowering agents.

But her team found that 4 months of injections with the engineered leptin boosted patients' blood levels of the hormone, cut their triglycerides and improved their blood sugar levels. And during leptin treatment, the women were able to discontinue on their diabetes therapies. The treatment "really made a big impact on their quality of life," said Oral, who was with the National Institute of Diabetes and Digestive and Kidney Diseases in Bethesda, Maryland, at the time of the study.

According to the team, along with this success in improving the disorder, the study also indicates the importance of body fat and leptin levels in maintaining a normal metabolism, Specifically, adequate leptin levels appear necessary for normal insulin sensitivity.

This would be in addition to its already-recognized job in helping r egulate appetite. Leptin has been called the obesity hormone--and has been mainly studied in this context--because leptin levels rise in proportion to body fat, and obese individuals have been thought to have leptin resistance.

Animal research has suggested that a lack of leptin may be involved in the development of insulin resistance, but this is the first evidence in humans that this may be the case. She said that future research should look into how leptin levels might factor into type 2 diabetes, the common form of diabetes that is closely linked to obesity and is preceded by the development of insulin resistance.

The study was funded by the US National Institutes of Health and the Thousand Oaks, California-based pharmaceutical company Amgen, which supplied the leptin product.


Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Obesity raises IVF miscarriage risk
3. Obesity a risk for pancreatic cancer
4. Obesity shortens lifespan
5. Is Obesity a risk factor?
6. Obesity a global problem
7. Obesity increases health costs
8. Obesity in children a risk factor for diabetes
9. Decrease of Hunger Hormone after Obesity Surgery
10. Obesity risk for immobilized adults
11. Obesity risk can be reduced by eating breakfast regularly
Post Your Comments:

(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
Breaking Medicine Technology: